2026 ICD-10-CM Diagnosis Code H71.93Unspecified cholesteatoma, bilateral

ICD-10-CM Codes›H60–H95›H65-H75›H71

ICD-10-CM H71.93
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

H71.93 is a billable ICD-10-CM diagnosis code for unspecified cholesteatoma, bilateral. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 154 through 156. Coders also document this condition as cholesteatoma of bilateral middle ears. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Diseases of middle ear and mastoid (except otitis media).

Code Identity

ICD-10-CM Code
H71.93
Billable Status
Yes — Valid for Submission
Code Describes
Unspecified cholesteatoma, bilateral
Short Description
Unspecified cholesteatoma, bilateral
Same as the full description in the CMS dataset.
Parent Code
H71.9
Unspecified cholesteatoma

Code Classification

ChapterH60–H95Diseases of the ear and mastoid process
SectionH65-H75Diseases of middle ear and mastoid
CategoryH71Cholesteatoma of middle ear
This CodeH71.93Unspecified cholesteatoma, bilateral

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Cholesteatoma of bilateral middle ears
  • Cholesteatoma of left middle ear
  • Cholesteatoma of right middle ear

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR EAR002
Diseases of middle ear and mastoid (except otitis media)
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Cholesteatoma

    a non-neoplastic mass of keratin-producing squamous epithelium, frequently occurring in the meninges; bones of the skull, and most commonly in the middle ear and mastoid region. cholesteatoma can be congenital or acquired. cholesteatoma is not a tumor nor is it associated with high cholesterol.

  • Cholesteatoma, Middle Ear

    a mass of keratin-producing squamous epithelium that resembles an inverted (suck-in) bag of skin in the middle ear. it arises from the eardrum (tympanic membrane) and grows into the middle ear causing erosion of ear ossicles and mastoid that contains the inner ear.

Patient EducationClinical

Ear Infections

Ear infections are the most common reason parents bring their child to a doctor. Three out of four children will have at least one ear infection by their third birthday. Adults can also get ear infections, but they are less common.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert H71.93 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
385.30 Cholesteatoma NOS
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About H71.93Overview

Is H71.93 (Unspecified cholesteatoma) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report unspecified cholesteatoma, bilateral on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does H71.93 group to?

When unspecified cholesteatoma, bilateral is the principal diagnosis on an inpatient stay, it groups to MS-DRG 154, 155, 156, with relative weights from 0.6911 to 1.5635 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of H71.93?

Under the General Equivalence Mappings, unspecified cholesteatoma, bilateral converts to ICD-9-CM 385.30 (cholesteatoma NOS). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.